Efficacy of Bromfenac 0.09% in Prevention and Treatment of Pseudophakic CME When Used Preoperatively and Postoperatively by Melissa M. Cable, MD, FAAO,

Slides:

Advertisements

Similar presentations

GH.Naderian, M.D.. Supra choroidal hemorrhage Cystoid macular edema Retinal detachment.

Advertisements

ASCRS-ASOA Early Regression of Limbal Relaxing Incisions in Phacoemulsification Patients: At 1 and 6 Weeks Postoperatively by Melissa M. Cable, MD,

CATARACT SUEGRY AND DIABETES Indications of surgery: 1) Visual loss 2)Surveillance of retinopathy 3)Laser therapy.

Sérgio Kwitko, Tiago Lansini, Andressa P Stolz, Diane R Marinho Authors have no financial interest in the subject matter of this poster.

1 Intraocular Pressure Spikes in Difluprednate Ophthalmic Emulsion 0.05% for Postoperative Cataract Inflammation by Melissa M. Cable, FAAO, FACS Discover.

Long-Term Follow-Up of Toric Intraocular Lens Implantation for Keratoconus Alejandro Navas, MD, MSc, Martha Jaimes, MD, Jesús Cabral, MD, Arturo Ramirez.

Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection Abstract Purpose: To evaluate pseudophakic cystoid macular edema.

Optical Coherence tomography Imaging of Spontaneous closure of Psuedophakic full thickness macular hole, 8 months post operative Dr. Jenin Patel Lotus.

Anupama Kotha 1, Simar J. Singh 1, William B. Trattler 1,2, Carlos Buznego 1,2 The authors have no financial interest in the subject matter of this poster.

A Prospective, Randomized, Comparative Evaluation of Patients with Contralateral Implantation of Two Aspheric Acrylic Intraocular Lenses R. Cionni, MD.

Eltutar, Kadir; Akcetin, Tulay A.; Ozcelik, N. Demet Istanbul Education and Research Hospital Department of Ophthalmology The authors state that they have.

ARCHITHA DEVATI P.3 CATARACT. Basic Overview Lens = part of the eye that focuses light on the retina.

Minnesota Eye Consultantswww.mneye.com Outcomes of Presbyopic IOLs Parag Parekh, MD, MPA Mona Fahmy, OD David R. Hardten, MD, FACS ASCRS Poster ID:

INTRAOPERATIVE FLAP COMPLICATIONS IN LASIK SURGERY PERFORMED BY OPHTHALMOLOGY RESIDENTS IN TRAINING Arturo Gómez-Bastar MD Arturo Ramirez-MirandaMD Lorena.

Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Macular Edema After Cataract Surgery Diabetic Retinopathy Clinical Research Network.

Dislocation of the DSEK Donor Graft into the Posterior Segment An Intraoperative Complication in DSEK Surgery Mark M Fernandez MD, Mark S Gorovoy MD, George.

Retrospective Comparison of 3177 Eyes Implanted with Presbyopic IOLs Carlos Buznego MD Elizabeth A. Davis MD, FACS Guy M. Kezirian MD, FACS William B.

Phacoemulsification with Goniosynechialysis in the Management of Refractory Acute Angle-closure Glaucoma Ghasem Fakhraie*, MD, Mahmoud Jabbarvand, MD,

Intraocular lens dislocation secondary to haptic torsion Lawrence E. Lohman, MD FACS Matthew C. Willett, MD.

The Effect of the Restor Multifocal IOL on Frequency Doubling Perimetry Elizabeth Yeu, MD1, Elizabeth Woznak, BS2, Nicole Kesten, BS2, Steven VL Brown,

ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.

Bryan Y Kim 1, Shintaro Kanayama MD PhD 1, Tueng T Shen MD PhD 1, Thomas E Gillette MD 2 1 University of Washington Department of Ophthalmology, 2 Eye.

Factors Associated with Changes in Visual Acuity and OCT Thickness at 1 Year after Treatment for Diabetic Macular Edema Sponsored by the National Eye Institute,

G. Jacob 1,2, C. Bouchard 2, S. Kancherla 1. Edward Hines, Jr. VA Hospital, Hines, IL, Department of Ophthalmology 1. Loyola University Medical Center,

The Second Report of The National cataract Surgery Registry PATIENTS’ CHARACTERISTICS Table 1.1: Age Distributions.

Autologous serum eye drops in severe post-LASIK dry eye.

Change in Patient-Reported Outcomes and Visual Acuity After Bilateral Implantation of Apodized Diffractive +3.0 IOLs Stephen Lane, MD Consultant, Alcon.

Durezol™ (difluprednate ophthalmic emulsion) 0.05% BID or QID starting 1 day before cataract surgery for treatment of postoperative inflammation and pain.

Comparison of Bromfenac vs. Ketorolac During the Induction Phase of Treatment with Topical Cyclosporine for Dry Eye Patients Barry A. Schechter, MD Florida.

Purpose: Introduction:  At initial evaluation: For post-op day # 0 patients: Pre-op VA was 20/50.6 (0.395 ± 0.198); Post-op VA was 20/102.0 (0.196 ± 0.162);

Glaucoma and Penetrating Keratoplasty : Incidence, Risk Factors, and Outcomes Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.

Methotrimeprazine-induced Corneal Deposits and Cataract Jae-Woong Koh (MD/PhD) Seong-Taeck Kim (MD) Department of Ophthalmology, Chosun University College.

Arslan Osman Sevki, Toker Mustafa Ilker, Yildirim Rengin, Ozdamar Akif, Sevim Okay, Gursoy Huseyin, Ozkok Ahmet Department of Ophthalmology Istanbul University.

Astigmatism management with toric intraocular lenses in cataract patients Adriano Guarnieri 1-2, Luis W. Lu 3-4, Alfonso Arias- Puente INCIVI, Madrid,

Update on Prevention, Diagnosis & Treatment of Diabetic Macular Edema (DME) Part 4 A. Paul Chous, MA, OD, FAAO Specializing in Diabetes Eye Care & Education.

P91: Clinical Performance of Phakic Angle-Supported Investigational IOL in Prospective Global Trials, ASCRS 2010, Boston P91: Clinical performance of phakic.

Phototoxic Maculopathy After Scleral Sutured IOL Implantation NC CHO, DW LEE, EY KWEON, MJ KIM Department of Ophthalmology, Chonbuk National University.

Jamie Ng, Marcus Tan, Lennard Thean National University Health System

Endothelial Keratoplasty in Patients With an Anterior Chamber Intraocular Lens: A Montreal Experience Georges M. Durr, MD 1,2 Johanna Choremis, MD, FRCSC.

Prospective, Randomized, Double-Blind Study Comparing Nepafenac 0.1% (Nevanac™) and Bromfenac Sodium 0.09% (Xibrom™) in Post-Op Cataract Patients Hon-Vu.

Miguel A. López M.D., María A. González Reiley M.D. The authors have no financial interest in the subject matter of this poster.

The authors have no financial interest in the subject matter of this poster. FINANCIAL DISCLOSURES.

Combined cataract surgery and endoscopic cyclophotocoagulation in patients with glaucoma without prior incisional glaucoma surgery Matthew P. Traynor,

LONG TERM OUTCOMES OF RESTOR IOL IMPLANTATION Lori Dao, Orkun Muftuoglu, V. Vinod Mootha, Steven M. Verity, R. Wayne Bowman, H. Dwight Cavanagh, James.

Uveitic Macular Edema Nihal Elshakankiry, MD, PhD Professor of Ophthalmology Rowayda M. Amin, MSc Assistant Lecturer of Ophthalmology Alexandria University.

بسم اللة الرحمن الرحيم. Limbal relaxing incisions versus penetrating limbal relaxing incisions for the management of astigmatism in cataract surgery Sara.

Efficacy of Topical Azithromycin & Cyclosporine A(CsA) vs CsA Alone in the Treatment of Dry Eyes Associated with Blepharitis Kenneth A. Beckman, M.D.,

DSEK for the treatment of endothelial disease in India -Initial Experience in 80 eyes- Authors have no financial interest Dr Ashish Nagpal MD, FRCS Dr.

Yonca Aydin Akova MD, Leyla Erkanli Asena MD

Hongseok Yang, M.D. Dae Hee Kim, M.D. Department of Ophthalmology, Ajou University School of medicine, Suwon, Korea The authors have no financial interest.

Get the Best Cataract Eye Surgery. What is Cataract Eye Problem? Cataract develops when protein buildups in the lens of eye thereby causing opaqueness.

Visual prognostic indicators in traumatic macular hole surgery SGN

Uveitis CTP Egla Rabinovich, Sheila Angeles-Han, Drew Lasky and Mindy Lo For the CARRA Uveitis working Group.

Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Inhibition of Neovascularization but Not Fibrosis.

SYMPATHETIC OPHTHALMIA: EXPERIENCE IN A TERTIARY REFERRAL CENTER

Pseudoexfoliation syndrom and cataract: results and complication frequency in immature and mature cataract surgery Marijana Bilen Babić Department of.

Analysis of Macular Edema after Cataract Surgery in Patients with Diabetes Using Optical Coherence Tomography Stephen J. Kim, MD, Robert Equi, MD, Neil.

Ocular Manifestations of Diabetes

Jennifer H. Hung, MD Kristiana D. Neff, MD Department of Ophthalmology

Wavefront Optimized Retreatment after Prior Wavefront

World Cornea Congress VI April 7-9, 2010

Prospective Study Comparing Outcomes of Torsional versus Traditional Phacoemulsification Systems on Dense Cataracts Bonnie An Henderson MD, Kelly J Grimes.

Early Experience with Descemet’s Stripping Automated Endothelial Keratoplasty Combined with Phacoemulsification: Clinical and Refractive Outcome University.

J. Fernando Arevalo, MD FACS Clínica Oftalmológica Centro Caracas

Sarosh A. Janjua MD1, Sandra L. Cremers MD FACS1

Anil Vedula MD Financial Disclosures: None Richard M. Awdeh MD

The authors have no financial interest

Postoperative Complications Following Descemet-Stripping Automated Endothelial Keratoplasty in Patients with Prior Glaucoma Surgery Melissa B Daluvoy.

Gowri Pachigolla, M.D., Steven Verity, M.D.,

Karen Chia, MD Chan Tat Keong, MD Peter Tseng, MD Doric Wong, MD

Presentation transcript:

Efficacy of Bromfenac 0.09% in Prevention and Treatment of Pseudophakic CME When Used Preoperatively and Postoperatively by Melissa M. Cable, MD, FAAO, FACS Discover Vision Centers *Author has relationships with the following companies with or without honoraria: Allergan, Alcon, B&L, Ista, Inspire, Ocular Therapeutix

ASCRS 2010 Purpose To evaluate the efficacy of a topical ophthalmic non- steroidal anti-inflammatory in preventing symptomatic pseudophakic cystoid macular edema in the initial three months following phacoemulsification surgery when dosed pre and post-operatively.

ASCRS 2010 Methods Retrospective review of 1020 charts of all patients who had uneventful phacoemulsification and intraocular lens placement by one surgeon over a 30 month time period. Patients were instructed to use bromfenac 0.09% (ISTA Pharmaceuticals) twice daily beginning three days prior to surgery and twice daily until gone after surgery.

ASCRS 2010 Methods Patients were evaluated with Snellen visual acuity chart at one day, one week, six weeks, and for any interim visits. Patients underwent dilated fundus exam with 90 diopter lens at one week. Patients with decreased vision and/or suggestive fundus findings were referred for macular OCT and/or fluorescein angiography.

ASCRS 2010 Results Five eyes of three patients of 1020 cases (0.5%) were confirmed to have pseudophakic cystoid macular edema by OCT and in two cases, additional confirmation by flourescein angiography was obtained. In this group one patient had documented pre-existing epiretinal membrane.

ASCRS 2010 Results The mean onset of pseudophakic cystoid macular edema was five weeks with a mean visual acuity at that time of logmar (app. 20/50). Mean time to resolution after onset of pseudophakic cystoid edema was 7.6 weeks and resolution was confirmed by OCT.

ASCRS 2010 Results Mean age of patients diagnosed was 66 years of age. Final best corrected visual acuity was logmar (20/30). There were no adverse ocular or systemic events.

ASCRS 2010 Conclusion Bromfenac 0.09% used bid three days prior to phacoemulsification and lens implantation and bid until gone after surgery appears to be highly effective in preventing pseudophakic cystoid macular edema.

ASCRS 2010 Conclusion In this study, two patients without systemic or ocular risk factors experienced pseudophakic CME. Treatment of pseudophakic CME with bromfenac 0.09% appears to be an effective way to reduce the signs of CME by OCT and improve visual acuity.

ASCRS 2010 About the Author Melissa M. Cable, MD, FAAO, FACS, is a board-certified ophthalmologist with Discover Vision Centers in Kansas City, MO., specializing in gentle no-stitch cataract surgery, ocular disease and cosmetic procedures. Dr. Cable graduated at the top 5% of her class in both her undergraduate and medical degree programs at Louisiana State University. She completed a residency in ophthalmology at the University of Missouri—Kansas City before joining Discover Vision Centers in Dr. Cable is one of only six partners in the company. With 35 doctors, 9 locations and 3 surgery centers located in the Kansas City Metro area, Discover Vision Centers has become one of the largest private ophthalmic medical-surgical practices in the United States.

ASCRS 2010 Thank you! Contact Information: Melissa M. Cable, MD, FAAO, FACS Partner – Discover Vision Centers, Kansas City Phone: Fax: